한글목차

미주신경 자극 세계 시장 전망은 유망하며 병원, 신경과 클리닉, 외래수술센터(ASC), 연구센터 시장에서 기회가 있습니다. 미주신경 자극 세계 시장은 2025-2031년 5.3%의 연평균 복합 성장률(CAGR)로 2031년까지 약 7억 달러에 달할 것으로 예측됩니다. 이 시장의 주요 촉진요인은 신경 질환의 유병률 증가와 미주신경 자극 요법에 대한 인식 증가입니다.

• Lucintel의 예측에 따르면, 제품 카테고리에서 임베디드 디바이스는 예측 기간 동안 높은 성장세를 보일 것으로 예측됩니다.
• 최종 용도별로는 병원이 가장 높은 성장세를 보일 것으로 예측됩니다.
• 지역별로는 북미가 예측 기간 동안 가장 높은 성장세를 보일 것으로 예측됩니다.

미주신경 자극 시장의 전략적 성장 기회

미주신경 자극 시장은 이러한 방법의 필요성이 더욱 절실해짐에 따라 전략적 성장 기회가 여전히 많이 남아 있습니다. 주요 성장 기회로는 정신 건강 부문의 적응증 확대, 차세대 장치 개발, 신흥 경제 국가 진출, 연구 개발 협력, 환자 치료 개선 등이 있습니다. 이러한 기회를 통해 기업은 시장에서 입지를 구축하고 효과적인 치료에 대한 수요를 충족시킬 수 있습니다.

• 기타 정신질환에 대한 VNS 기술 발표 성장 기회 중 하나는 불안장애/공황장애, PTSD, 기타 정신질환 치료에 VNS를 적용하는 것입니다. 이러한 질환의 치료에 VNS의 효능을 뒷받침하는 연구가 늘어남에 따라 의료 서비스 제공업체는 VNS를 치료 옵션으로 고려해야 합니다. 이러한 추세는 이러한 질환의 치료에 VNS 치료의 활용을 확대하고 시장을 확대하는 데 도움이 될 것입니다.
• 차세대 기기의 실용화를 위한 기기 제조업체와의 협업 더 나은 기능과 사용자 경험을 제공하는 차세대 VNS 기기 개발에 있어 기기 제조업체와의 협력도 큰 기회입니다. 환자에게 더 나은 자극을 줄 수 있는 소형 무선 기기 등의 혁신은 환자의 순응도와 만족도를 높일 수 있습니다. 최첨단 장비를 제조하기 위한 연구개발에 투자함으로써 업계는 시장에서 전략적 입지를 구축하고 새로운 시장에 진입하여 매출을 향상시킬 수 있습니다.
• 전략적 시장 개척: 시장 개척은 VNS 제조 기업에게 전략적 기회이기도 합니다. 아시아 및 라틴아메리카에서 의료 시스템이 발전하고 신경 자극 치료에 대한 인식이 높아짐에 따라 기업은 새로운 환자를 대상으로 할 수 있습니다. 제품을 마케팅하고 현지 시장 수요에 맞게 조정하여 접근성을 높이고 수요를 창출하여 VNS 시장을 확대할 수 있습니다.
• R&D 파트너십 추진: 의료기기 기업과 과학 기관과의 공동 작업을 장려함으로써 VNS 기술의 빠른 발전을 촉진할 수 있습니다. 이러한 공동 연구는 새로운 용도를 개발하거나 기존 용도를 강화하거나 치료법을 변경 및 조정하는 데 도움이 될 수 있습니다. 기업이 공동 연구 개발 활동을 수행하면 자원을 쉽게 모으고, VNS 치료의 발전에 도움이 되며, 기업이 산업의 최전선에 머무를 수 있습니다.
• 환자 중심 서비스 개선: 교육적, 지원적 노력을 통해 환자 중심 서비스를 개선하는 것도 유망한 방향입니다. 환자가 VNS 치료의 잠재적 이점에 대해 알게 되면 치료 순응도가 높아질 가능성이 높습니다. 환자 지원 시스템이 강화되면 치료 성과와 만족도가 향상되고, 더 많은 사람들이 건강 문제에 대처하는 효과적인 방법을 찾게 되어 VNS 치료에 대한 수요가 증가할 가능성이 높습니다.

이러한 전략은 미주신경자극요법 시장 수요 변화에 대응하고 있습니다. 기업들은 시술의 폭을 넓히고, 새로운 장비를 도입하고, 새로운 시장에 진출함으로써 성장 가능성과 경쟁력을 높일 수 있습니다. 또한, 치료를 원하는 환자들에게 가장 현실적인 선택지 중 하나로서 협력 체계와 환자 중심의 자세도 VNS 치료 시장 확대에 기여하고 있습니다.

미주신경자극요법 시장 성장 촉진요인 및 과제

이해관계자들은 미주신경 자극 시장이 기술적 개선에서 규제 문제, 시장 환경에 이르기까지 여러 시장 성장 촉진요인 및 과제에 영향을 받는다는 것을 인식하고 있습니다. 특히 환경은 끊임없이 변화하고 있기 때문에 이러한 요소들은 매우 중요합니다. 주요 촉진요인으로는 신경 질환의 유병률 증가, 신경 자극 치료의 수용 확대, 첨단 기기, 유리한 규제, 의료비 지출 증가 등을 들 수 있습니다. 반면, 높은 가격, 대체 치료법, 규제 장벽, 인식 부족 등이 장애요인으로 작용할 수 있습니다.

미주신경 자극 시장을 견인하는 요인으로는 다음과 같은 것들이 있습니다.

• VNS 치료를 찾는 행동의 인종적, 지리적 결정 요인: 우울증, 간질과 같은 신경 질환의 발생률 증가는 VNS 시장의 주요 촉진요인 중 하나입니다. 더 많은 사람들이 효과적인 치료 수단을 계속 찾고 있기 때문에 VNS 치료공급은 증가할 것으로 예측됩니다. 이러한 발전으로 인해 의료 서비스 제공업체는 수요 증가에 대응하기 위해 전략과 관행을 조정해야 합니다.
• 환자 인식 증가: VNS 치료법에 대한 환자 인식 증가도 VNS 시장의 주요 촉진요인으로, VNS 치료에 대한 지식이 풍부한 환자는 건강 상태를 관리하기 위해 VNS 치료를 채택할 가능성이 높으며, VNS의 장점과 다양한 적용에 대한 정보는 교육, 교육 캠페인, 의료 활동 및 기타 정보 공유를 통해 점점 더 널리 퍼지고 있습니다. 교육 캠페인, 의료 캠페인 및 기타 정보 공유 활동을 통해 VNS의 장점과 다양한 응용에 대한 정보가 점점 더 널리 퍼지고 있습니다. 이는 VNS의 전체 시장 역학에 영향을 미치고 있습니다.
• 유리한 의료 규제 확대: VNS 치료에 대한 접근성을 개선하는 의료 규제의 개발이 성장을 가속하고 있습니다. 특히 고가 치료에 대한 의료 및 보험 적용에 대한 지원 확대는 환자의 치료비 부담을 줄여줍니다. 이러한 확대는 VNS 치료의 보급을 촉진하고 의료 서비스 제공업체 및 VNS 장비 제조업체에 새로운 길을 열어줄 것입니다.
• VNS의 기술적 진보: 장치의 소형화 및 무선 연결의 개발 등 VNS 시스템의 기술적 진보는 시장의 주요 촉진요인입니다. 이러한 발전은 환자들에게 보다 편안한 치료를 제공할 뿐만 아니라 의료 서비스 제공업체가 보다 정확하고 효과적인 치료를 제공할 수 있도록 돕고 있습니다. 기술과 개인화된 치료 전략의 조합은 VNS 장비에 대한 수요를 지속적으로 촉진하고 있습니다.

미주신경 자극 시장의 과제는 다음과 같습니다.

• VNS 장비와 치료의 높은 가격: VNS 치료의 보급을 가로막는 가장 큰 장애물 중 하나는 장비와 치료의 높은 가격입니다. 특히 신흥국에서는 많은 환자들에게 VNS 장비 및 관련 서비스 비용이 엄청나게 비쌀 수 있습니다. 이 문제는 시장 성장을 저해하고 상당수의 잠재적 환자들에게 이 기술에 대한 접근을 제한할 수 있습니다.
• 대체 치료와의 경쟁: 약물이나 다른 신경 자극 요법과 같은 대체 치료와의 경쟁은 VNS 치료의 채택을 방해할 수 있습니다. 대체 요법은 위험이 적고, 접근성이 높으며, 가격이 저렴하기 때문에 환자와 의료 서비스 제공업체에게 매력적인 선택이 될 수 있습니다.
• 시장 진입에 대한 규제 장벽: 지역별로 상이한 규제 과제, 특히 기기 승인 과정과 관련된 과제가 VNS 시장의 성장을 저해할 수 있습니다. 일부 지역에서는 까다로운 승인 절차로 인해 제품 출시가 늦어지고 새로운 치료법이 환자에게 도입되는 속도가 느려지고 있습니다.
• VNS에 대한 인식 부족: 환자와 의료 제공업체의 VNS에 대한 낮은 인식이 여전히 큰 문제입니다. 인지도 향상 캠페인이 진행되고 있지만, 인지도를 높이고 잠재적 사용자들에게 받아들여지기 위해서는 더 많은 노력과 시간이 필요합니다. 그때까지 시장의 성장은 예상보다 둔화될 것으로 보입니다.

이러한 시장 성장 촉진요인과 과제는 앞으로도 VNS 시장을 형성해 나갈 것으로 보입니다. 성장과 확장의 기회가 남아있지만, 이러한 과제를 해결하는 것이 전 세계적으로 VNS 요법이 지속적으로 성공할 수 있는 열쇠가 될 것으로 보입니다.

목차

제1장 주요 요약

제2장 세계의 미주신경 자극 시장 : 시장 역학

• 서론, 배경, 분류
• 공급망
• 산업 촉진요인과 과제

제3장 시장 동향과 예측 분석(2019-2031년)

• 거시경제 동향(2019-2024년)과 예측(2025-2031년)
• 세계의 미주신경 자극 시장 동향(2019-2024년)과 예측(2025-2031년)
• 제품별 : 세계의 미주신경 자극 시장
  • 이식형 장치
  • 외부 장치
• 생체 재료별 : 세계의 미주신경 자극 시장
  • 금속
  • 세라믹
  • 폴리머
• 용도별 : 세계의 미주신경 자극 시장
  • 간질
  • 우울증
  • 편두통
• 최종 용도별 : 세계의 미주신경 자극 시장
  • 병원
  • 신경과 클리닉
  • 외래수술센터(ASC)
  • 연구센터
  • 기타

제4장 지역별 시장 동향과 예측 분석(2019-2031년)

• 지역별 미주신경 자극 시장
• 북미의 미주신경 자극 시장
• 유럽의 미주신경 자극 시장
• 아시아태평양의 미주신경 자극 시장
• 기타 지역의 미주신경 자극 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영 통합
• Porter의 Five Forces 분석

제6장 성장 기회와 전략 분석

• 성장 기회 분석
  • 제품별 : 세계의 미주신경 자극 시장 성장 기회
  • 생체 재료에 의한 세계 미주신경 자극 시장 성장 기회
  • 용도별 : 세계의 미주신경 자극 시장 성장 기회
  • 최종 용도별 : 세계의 미주신경 자극 시장 성장 기회
  • 지역별 미주신경 자극 시장 성장 기회
• 세계 미주신경 자극 시장의 새로운 동향
• 전략 분석
  • 신제품 개발
  • 세계의 미주신경 자극 시장 능력 확대
  • 세계 미주신경 자극 시장에서의 인수합병(M&A) 및 합작투자(JV)
  • 인증 및 라이선싱

제7장 주요 기업 개요

• LivaNova
• ElectroCore
• Cerebral
• MicroTransponder
• Parasym

영문목차

The future of the global vagus nerve stimulation market looks promising, with opportunities in the hospital, neurology clinic, ambulatory surgical center, and research center markets. The global vagus nerve stimulation market is expected to reach an estimated $0.7 billion by 2031, with a CAGR of 5.3% from 2025 to 2031. The major drivers for this market are the growing prevalence of neurological disorders and the rising awareness of vagus nerve stimulation therapy.

• Lucintel forecasts that, within the product category, implantable device is expected to witness higher growth over the forecast period.
• Within the end use category, hospital is expected to witness the highest growth.
• In terms of region, North America is expected to witness the highest growth over the forecast period.

Gain valuable insight for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Vagus Nerve Stimulation Market

The vagus nerve stimulation market is currently experiencing several emerging trends. This is attributed to technological development, the increasing use of neurostimulation therapies, and changes in healthcare settings. Some trends focus on personalizing VNS treatment, digital health interconnections with VNS, an increased focus on research into new applications, entering the developing market, and improved client education. All these trends are changing the market landscape to improve the efficiency and availability of VNS therapies.

• Personalized VNS treatments: Personalized VNS treatments are taking root because modern stimulators can design individualized stimulation parameters for their clients. Adapting the VNS therapy to the particular features presented by each patient is expected to bring better results and improve patients' self-reports regarding their satisfaction. This trend is transformational concerning VNS, as healthcare providers are now in a position to plan their interventions and evaluate the outcome more efficiently, which warrants a higher rate of clinical uptake of the devices.
• Integration with digital health technologies: The combination of VNS with mobile health applications is changing how patients are managed. These technologies enable ongoing feedback on the patient's response and the ability to adjust stimulation parameters where applicable. More connected VNS devices and digital platforms improve patient compliance and help healthcare providers collect more data than they otherwise could to assist in modifying treatment regimens appropriately, which helps augment overall treatment outcomes.
• Increased research on new applications: Further research into the probable uses of VNS beyond its treatment of epilepsy and depression appears to be an increasing trend in the market. Investigations are being carried out on the use of the equipment for treating obesity, migraine, chronic pain, and other ailments. With the increasing volume of clinical evidence, VNS may emerge as a treatment for many diseases rather than just one or two, extending its applicability to manufacturers and presenting new possibilities for them to create and introduce unique devices into the market.
• Expansion into emerging markets: The expansion of VNS therapies into emerging markets can be regarded as one of the key trends due to the expansion of healthcare infrastructure. There is a growing demand in regions such as Asia-Pacific and Latin America as a result of increased investment in healthcare and awareness of neurostimulation therapies. There are growth opportunities that can be exploited by organizations that re-strategize to suit the regional markets and improve access to VNS therapies for the underserved populations.
• Improved patient education: Improving education for patients is very important and probably one of the most effective ways to increase the usage of VNS. Informing patients about the advantages of VNS therapies and their mechanisms via educational campaigns may help eliminate misconceptions and enhance the acceptance of VNS. Helping patients understand the treatment options available to them will likely improve compliance and engagement with treatment, driving VNS market growth as more patients seek this alternative therapy for their conditions.

These emerging trends are redefining the vagus nerve stimulation market by moving the treatment toward individualization, patient motivation, and broader access to VNS therapies. More growth possibilities arise as disruptive technologies and research insights are combined with the ability to penetrate developing markets in the wellness industry. As patient education improves, there is an expectation for a better market for VNS therapies with more acceptance and usage.

Recent Developments in the Vagus Nerve Stimulation Market

Recently, milestones achieved in the vagus nerve stimulation market are evidence of improvements in services, enhanced patient participation, and strong regulatory support for neurostimulation treatments. Among the innovations are advanced devices, joint research initiatives, better healthcare systems, increasing clinical indications for further applications, and improved patient education. The expansion of the VNS market due to these developments positions it as an important therapeutic option for treating numerous diseases.

• Advanced VNS devices: The availability of advanced VNS devices with higher therapeutic efficacy and safety is one of the developments in the market. Devices are being developed to be smaller and more powerful, providing personalized stimulation options. These technologies result in better comfort and active participation of patients, which eventually increases clinical uptake of these devices and compliance among people with epilepsy and other diseases.
• Collaboration in research: Collaborative research activities between universities, research institutions, healthcare facilities, and medical device companies are accelerating the growth of VNS technology. These relationships seek to identify more uses for VNS and improve current devices. The combined expertise and resources propel the invention of new treatment options, thereby enhancing sales growth opportunities and expanding the general market for VNS treatments for several medical conditions.
• Stronger government healthcare policies: Stronger government healthcare policies on neurostimulation therapy have supported the VNS market. More VNS devices and their treatments are now covered by insurance, which allows more patients to seek therapy. The high performance of healthcare systems encourages the development of effective therapies to target challenging diseases such as epilepsy and depression. Over time, this means a growing VNS market with wider use and higher rates of uptake by both patients and providers.
• Emerging clinical evidence based on VNS use with neurostimulation for co-morbidities other than epilepsy: VNS strengthens and expands the pharmaceutical market with new prospects because there is growing clinical evidence of its effectiveness for application in chronic pain and obesity, aspects that are likely to contribute to the market's expansion. As VNS becomes more evidence-based in practice, companies are more likely to direct funds into VNS device development.
• More advanced techniques for providing increased patient education: More advanced techniques for providing increased patient education regarding VNS therapies have been developed, improving knowledge and comprehension for potential patients and healthcare professionals. Patient acceptance and compliance with VNS can be enhanced by educational programs that explain the contraindications, benefits, and risks of VNS. These campaigns are expected to create more awareness for these therapies, driving demand in the market and improving patient quality of life.

These recent developments are influencing the growth of the vagus nerve stimulation market by addressing treatment gaps, increasing market penetration, and promoting innovations. Further progress is driven by the introduction of advanced devices, cooperative studies, and enthusiastic healthcare policies, while increased clinical practice and patient education facilitate market expansion. Consequently, the VNS market is growing and fast becoming an essential part of healthcare systems for various disease conditions.

Strategic Growth Opportunities for Vagus Nerve Stimulation Market

The vagus nerve stimulation market still has plenty of strategic growth opportunities as the need for such methods becomes more pressing. Some of the key growth opportunities include broadened indications in the area of mental health, development of next-generation devices, expansion into fast-growing economies, collaboration in research and development, and improving patient care. Fulfilling these opportunities would position companies well in the market and help satisfy the demand for effective treatment.

• Employing VNS technology for other mental health disorders: One of the growth opportunities is extending the applications of VNS in the treatment of anxiety/panic disorders, PTSD, and other mental health disorders. As more studies support the efficacy of VNS in treating these conditions, healthcare providers must consider it as a treatment option. This trend can lead to greater utilization of VNS therapies for treating these diseases, thus broadening the market.
• Collaboration with device manufacturers for commercialization of next-generation devices: Collaboration with device manufacturers for developing next-generation VNS devices that provide better functionality and user experience is another significant opportunity. Innovations such as small, wireless devices that allow better stimulation of patients can boost adherence and satisfaction among patients. By investing in R&D to produce state-of-the-art devices, industries will position themselves strategically in the market and break into new markets, enhancing sales.
• Strategic development of emerging markets: Developing emerging markets is another strategic opportunity for VNS production companies. As health systems develop and awareness of neurostimulation treatments grows in Asia and Latin America, companies have new patients to target. Marketing and adapting products to local market demands will increase availability and create demand, thus growing the VNS market.
• Promoting advances in research and development partnerships: Encouraging joint efforts between medical instrument corporations and scientific institutions may foster faster advancements in VNS technologies. Such collaborations can help in developing new uses, enhancing existing ones, or modifying and fine-tuning treatment methods. If companies engage in collaborative R&D activities, they will be in a better position to pool resources, which will assist in the progress of VNS therapies and help the companies remain at the forefront of the industry.
• Improving patient-focused services: Improving patient-focused services through educational and supportive initiatives is also a promising direction. When patients become informed about the potential benefits of VNS therapies, they are likely to embrace compliance with the therapy. Well-developed patient support systems are likely to improve treatment outcomes and satisfaction, increasing the demand for VNS therapies as a larger number of people seek effective ways to address their health issues.

These strategies are responding to the changing demands within the vagus nerve stimulation market. Companies can increase growth potential and competitiveness by broadening the range of procedures, introducing new devices, and entering new markets. Cooperation and a focus on patients also help expand the market for VNS therapy as one of the most viable options for patients seeking treatment.

Vagus Nerve Stimulation Market Driver and Challenges

Stakeholders recognize that the market for vagus nerve stimulation is influenced by several drivers and challenges, ranging from technological improvements to regulatory issues and even the market environment. These elements are critical, especially as the environment is continuously changing. Key drivers include the increasing prevalence of neurological disorders, growing acceptance of neurostimulation therapies, advanced devices, favorable regulations, and more spending on healthcare. On the contrary, challenges include high prices, alternative treatment methods, regulatory barriers, and lack of awareness.

The factors responsible for driving the vagus nerve stimulation market include:

• Ethnic and geographic determinants in treatment-seeking behavior for VNS: The increasing incidence of neurological disorders such as depression and epilepsy is one of the main drivers of the VNS market. As more individuals continue to seek effective therapeutic measures, the supply of VNS therapies is likely to increase. This development requires healthcare providers to adjust their strategies and practices to accommodate the growing demand.
• Increasing patient awareness: Growing awareness among patients about available therapies is also a major driver of the VNS market. Patients who are more knowledgeable about VNS therapies will likely adopt them to manage their health conditions. Information about the benefits of VNS and its various applications is becoming increasingly widespread due to educational campaigns, healthcare initiatives, and other information-sharing activities. This is influencing the overall market dynamics for VNS.
• Expansion in favorable healthcare regulations: Healthcare regulatory developments that improve access to VNS treatments are helping to drive growth. Increased support for healthcare and insurance coverage, particularly for expensive treatments, reduces the burden of treatment costs for patients. This expansion can stimulate greater adoption of VNS therapy, opening new avenues for healthcare providers and VNS device manufacturers.
• Technological advances in VNS: Technological improvements in VNS systems, such as the development of smaller devices and wireless connections, are a major driver of the market. These developments not only make the treatments more comfortable for patients but also help healthcare providers deliver more precise and effective treatments. The combination of technology and personalized care strategies continues to fuel the demand for VNS devices.

Challenges in the vagus nerve stimulation market include:

• High prices of VNS devices and therapy: One of the biggest obstacles to the wider adoption of VNS treatments is the high price of both the devices and the therapy. The cost of VNS devices and related services can be prohibitively expensive for many patients, especially in developing countries. This issue hampers market growth and may limit access to the technology for a significant number of potential patients.
• Competition from alternative treatment options: Competition from alternative treatments such as drugs or other neurostimulation therapies may hinder the adoption of VNS therapies. Alternatives may present fewer risks, be more accessible, or be more affordable, making them attractive options for patients and healthcare providers.
• Regulatory barriers to market entry: Regulatory challenges in different regions, especially regarding device approval processes, can impede the growth of the VNS market. Stringent approval processes in some regions delay product launches and reduce the pace at which new treatments are introduced to patients.
• Lack of awareness about VNS: Limited awareness about VNS among patients and healthcare providers remains a significant challenge. Although awareness campaigns have been implemented, it will take more effort and time to raise awareness and achieve greater acceptance among potential users. Until then, the market will likely see slower growth than anticipated.

These drivers and challenges will continue to shape the market for VNS. While opportunities for growth and expansion remain, addressing these challenges will be key to ensuring the continued success of VNS therapies across the globe.

List of Vagus Nerve Stimulation Companies

Companies in the market compete based on product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies, vagus nerve stimulation companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the vagus nerve stimulation companies profiled in this report include-

• LivaNova
• ElectroCore
• Cerebral
• MicroTransponder
• Parasym

Vagus Nerve Stimulation by Segment

The study includes a forecast for the global vagus nerve stimulation market by product, biomaterial, application, end use, and region.

Vagus Nerve Stimulation Market by Product [Analysis by Value from 2019 to 2031]:

• Implantable Device
• External Device

Vagus Nerve Stimulation Market by Biomaterial [Analysis by Value from 2019 to 2031]:

• Metallic
• Ceramics
• Polymeric

Vagus Nerve Stimulation Market by Application [Analysis by Value from 2019 to 2031]:

• Epilepsy
• Depression
• Migraine

Vagus Nerve Stimulation Market by End Use [Analysis by Value from 2019 to 2031]:

• Hospitals
• Neurology Clinics
• Ambulatory Surgical Centers
• Research Centers
• Others

Vagus Nerve Stimulation Market by Region [Analysis by Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Vagus Nerve Stimulation Market

Vagus nerve stimulation (VNS) offers a very effective treatment for many medical problems like epilepsy and depression. New technologies and a growing understanding of the role of the vagus nerve in general are contributing to the growth of this market. The landscape in countries such as the U.S., China, Germany, Indian, and Japan is improving significantly across the dimensions of national VNS applications, regulations, and market access.

• United States: The U.S. occupies the frontline position in the VNS market along with other advanced countries, and this has a significant influence on the treatment of epilepsy and depression. Meanwhile, new approvals for VNS devices and advanced stimulation techniques have improved patient care and treatment options. Increased usage of telemedicine has improved procedures as well as the utilization of VNS therapies, and the expansion of health insurance policies in the country has also contributed to the increased acceptance of such therapies throughout the U.S.
• China: The growth of the VNS market in China is supported by growing investments in the healthcare sector and rising awareness about neurostimulation therapies. Further specific studies in the Chinese context have fostered partnerships between national manufacturers and foreign ones, introducing cutting-edge VNS devices to the market. Meanwhile, the market is supported by government measures that increase R&D capability for neurostimulation devices while targeting the enhancement of availability in both urban and rural areas. However, each market expansion path is still clouded with stringent regulatory concerns.
• Germany: The VNS market in Germany is mainly characterized by an innovative approach coupled with a high level of focus on R&D. Recent partnerships have been witnessed between manufacturers of medical devices and institutions of higher learning with the goal of developing VNS. Coverage for VNS therapies through health plans has certainly improved, allowing many more patients to be served. Furthermore, through awareness campaigns, patients and caregivers are being informed about VNS technology, thus creating a patient market for these therapies in the country.
• India: In India, VNS market entry has been catalyzed by the rise in the incidence of both epilepsy and mood disorders. Recent efforts to improve healthcare infrastructure and broaden the scope for advanced treatment have created a favorable ecosystem for VNS adoption. The innovation of VNS devices has also been enhanced by the collaboration of hospitals and medical technology companies. Making VNS therapies affordable and creating awareness about these therapies remain challenges that need to be addressed for wider market penetration.
• Japan: Japan's VNS market is expanding as it is witnessing an increasing number of patients looking for alternative therapies for epilepsy and depression. In recent years, other advancements have included beginning clinical investigations of VNS for new therapies, which factors into the creation of new indications for current devices. Additionally, there are research projects promoting neurostimulation technologies in Japan by the government, which will most likely contribute to market growth. Given these factors, potential barriers to the rapid influx of VNS into the market may be attributed to the regulatory situation and cultural issues regarding medical treatment.

Features of the Global Vagus Nerve Stimulation Market

Market Size Estimates: Vagus nerve stimulation market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Vagus nerve stimulation market size by various segments, such as by product, biomaterial, application, end use, and region in terms of value ($B).

Regional Analysis: Vagus nerve stimulation market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different products, biomaterials, applications, end uses, and regions for the vagus nerve stimulation market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the vagus nerve stimulation market.

Analysis of the competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers the following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the vagus nerve stimulation market by product (implantable device and external device), biomaterial (metallic, ceramics, and polymeric), application (epilepsy, depression, and migraine), end use (hospitals, neurology clinics, ambulatory surgical centers, research centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market, and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years, and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Vagus Nerve Stimulation Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Vagus Nerve Stimulation Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Vagus Nerve Stimulation Market by Product
  • 3.3.1: Implantable Device
  • 3.3.2: External Device
• 3.4: Global Vagus Nerve Stimulation Market by Biomaterial
  • 3.4.1: Metallic
  • 3.4.2: Ceramics
  • 3.4.3: Polymeric
• 3.5: Global Vagus Nerve Stimulation Market by Application
  • 3.5.1: Epilepsy
  • 3.5.2: Depression
  • 3.5.3: Migraine
• 3.6: Global Vagus Nerve Stimulation Market by End Use
  • 3.6.1: Hospitals
  • 3.6.2: Neurology Clinics
  • 3.6.3: Ambulatory Surgical Centers
  • 3.6.4: Research Centers
  • 3.6.5: Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Vagus Nerve Stimulation Market by Region
• 4.2: North American Vagus Nerve Stimulation Market
  • 4.2.1: North American Vagus Nerve Stimulation Market by Product: Implantable Device and External Device
  • 4.2.2: North American Vagus Nerve Stimulation Market by End Use: Hospitals, Neurology Clinics, Ambulatory Surgical Centers, Research Centers, and Others
• 4.3: European Vagus Nerve Stimulation Market
  • 4.3.1: European Vagus Nerve Stimulation Market by Product: Implantable Device and External Device
  • 4.3.2: European Vagus Nerve Stimulation Market by End Use: Hospitals, Neurology Clinics, Ambulatory Surgical Centers, Research Centers, and Others
• 4.4: APAC Vagus Nerve Stimulation Market
  • 4.4.1: APAC Vagus Nerve Stimulation Market by Product: Implantable Device and External Device
  • 4.4.2: APAC Vagus Nerve Stimulation Market by End Use: Hospitals, Neurology Clinics, Ambulatory Surgical Centers, Research Centers, and Others
• 4.5: ROW Vagus Nerve Stimulation Market
  • 4.5.1: ROW Vagus Nerve Stimulation Market by Product: Implantable Device and External Device
  • 4.5.2: ROW Vagus Nerve Stimulation Market by End Use: Hospitals, Neurology Clinics, Ambulatory Surgical Centers, Research Centers, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Vagus Nerve Stimulation Market by Product
  • 6.1.2: Growth Opportunities for the Global Vagus Nerve Stimulation Market by Biomaterial
  • 6.1.3: Growth Opportunities for the Global Vagus Nerve Stimulation Market by Application
  • 6.1.4: Growth Opportunities for the Global Vagus Nerve Stimulation Market by End Use
  • 6.1.5: Growth Opportunities for the Global Vagus Nerve Stimulation Market by Region
• 6.2: Emerging Trends in the Global Vagus Nerve Stimulation Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Vagus Nerve Stimulation Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Vagus Nerve Stimulation Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: LivaNova
• 7.2: ElectroCore
• 7.3: Cerebral
• 7.4: MicroTransponder
• 7.5: Parasym